» Articles » PMID: 21088043

Effect of Antipsychotics on Spontaneous Hyperactivity and Hypersensitivity to MK-801-induced Hyperactivity in Rats Prenatally Exposed to Methylazoxymethanol

Overview
Publisher Sage Publications
Specialty Pharmacology
Date 2010 Nov 20
PMID 21088043
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Exposure to methylazoxymethanol (MAM) at embryonic day 17 (E17) in the rat has been proposed to be a promising model for schizophrenia that mimics behavioural abnormalities and deficits in prefrontal cortex (PFC) networks. In this study, we investigated for the first time the effects of antipsychotics on abnormal behaviours observed in prenatally MAM-exposed rats. We first examined spontaneous and MK-801-induced locomotor activity in an open field in adult E17 MAM- or saline-exposed rats. Then, the effect of single injections of haloperidol, clozapine and risperidone was investigated in MAM- or sham-exposed rats on spontaneous and MK-801 (0.05 mg/kg)-induced hyperactivity. Risperidone more selectively counteracted the spontaneous hyperactivity in MAM than in sham rats, while haloperidol and clozapine induced similar effects on spontaneous locomotion in both groups. The main result of this study is that all the tested antipsychotics were more effective in attenuating the MK-801-induced hyperlocomotion in MAM than in sham rats. These findings further support the validity of E17 MAM exposure as a model for schizophrenia and add to its heuristic value in screening therapies for schizophrenia.

Citing Articles

The antipsychotic agent sulpiride microinjected into the ventral pallidum restores positive symptom-like habituation disturbance in MAM-E17 schizophrenia model rats.

Peczely L, Dusa D, Lenard L, Ollmann T, Kertes E, Galosi R Sci Rep. 2024; 14(1):12305.

PMID: 38811614 PMC: 11136981. DOI: 10.1038/s41598-024-63059-y.


Neonatal phencyclidine as a model of sex-biased schizophrenia symptomatology in adolescent mice.

Dutra-Tavares A, Souza T, Silva J, Semeao K, Mello F, Filgueiras C Psychopharmacology (Berl). 2023; 240(10):2111-2129.

PMID: 37530885 DOI: 10.1007/s00213-023-06434-3.


Methylation pattern and mRNA expression of synapse-relevant genes in the MAM model of schizophrenia in the time-course of adolescence.

Khan A, Thielen L, Le Pen G, Krebs M, Kebir O, Groh A Schizophrenia (Heidelb). 2022; 8(1):110.

PMID: 36481661 PMC: 9732294. DOI: 10.1038/s41537-022-00319-8.


The Antioxidant N-Acetyl-L-Cysteine Restores the Behavioral Deficits in a Neurodevelopmental Model of Schizophrenia Through a Mechanism That Involves Nitric Oxide.

Lopes-Rocha A, Bezerra T, Zanotto R, Lages Nascimento I, Rodrigues A, Salum C Front Pharmacol. 2022; 13:924955.

PMID: 35903343 PMC: 9315304. DOI: 10.3389/fphar.2022.924955.


Juvenile treatment with mGluR2/3 agonist prevents schizophrenia-like phenotypes in adult by acting through GSK3β.

Xing B, Han G, Wang M, Snyder M, Gao W Neuropharmacology. 2018; 137:359-371.

PMID: 29793154 PMC: 6050107. DOI: 10.1016/j.neuropharm.2018.05.019.